Intelligence Β· Clinical Pipeline

Metabolic & obesity R&D Pipeline

GLP-1, metabolic disease, obesity, and diabetes pipeline programs with sponsor and trial ID cross-links.

Programs
755

Quick answer

Metabolic & obesity: NovaPharmaNews indexes 755 metabolic & obesity clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. GLP-1, metabolic disease, obesity, and diabetes pipeline programs with sponsor and trial ID cross-links.

Top sponsors

Page 16 of 16

  1. Iron Isomaltoside injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Obesity

    small molecule active

    1 trial
  2. Kefir peptide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Obesity

    other active

    1 trial
  3. Kunxian capsule

    The First People's Hospital of Lianyungang

    Diabetic Nephropathy

    small molecule completed

    1 trial
  4. Lang Qingata

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    NASH

    small molecule active

    1 trial
  5. Low-fat milk group

    BRIGHT MINDS BIOSCIENCES INC.

    Metabolic Syndrome

    other completed

    1 trial
  6. Lubiprostone

    Takeda

    Diabetes Mellitus, Type 1

    small molecule terminated

    1 trial
  7. Mango

    BRIGHT MINDS BIOSCIENCES INC.

    Overweight or Obesity

    other completed

    1 trial
  8. Nut group

    BRIGHT MINDS BIOSCIENCES INC.

    Metabolic Syndrome

    other completed

    1 trial
  9. Olive oil

    Universe Pharmaceuticals INC

    Severe Obesity

    other completed

    1 trial
  10. Oral supplementation of vitamin D

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Obesity

    other completed

    1 trial
  11. PROGRAM

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Obesity

    other completed

    1 trial
  12. Peanuts

    United Therapeutics Europe Ltd

    Prediabetes

    other active

    1 trial
  13. Phase 1 Wonderlab Product

    Chongqing Precision Biotech Co., Ltd

    Diabetes

    other completed

    1 trial
  14. Phentermine

    Takeda

    Obesity

    small molecule completed

    1 trial
  15. Power Line Program

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Metabolic Health

    other completed

    1 trial
  16. Probiotics

    Sun Yat-sen University

    Cardiometabolic Risk Factors

    other completed

    1 trial
  17. Pueraria lobata radix

    The First People's Hospital of Lianyungang

    Type 2 Diabetes Mellitus

    small molecule active

    1 trial
  18. Redefine

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Obesity & Overweight

    other active

    1 trial
  19. Semaglutide

    GT Biopharma

    Obesity (Disorder)

    small molecule active

    1 trial
  20. Sniffing emotional tears

    Hospital Authority, Hong Kong

    Obesity

    mab completed

    1 trial
  21. Study product A (Wonderlab wonder4shape)

    Chongqing Precision Biotech Co., Ltd

    Overweight and Obesity

    other completed

    1 trial
  22. Tests of the expression of CXCL3 in various tissues

    The First People's Hospital of Lianyungang

    Diabetic Kidney Disease (DKD)

    other completed

    1 trial
  23. UMULINE NPH

    Takeda

    Type 2 Diabetes

    small molecule terminated

    1 trial
  24. Urinary EDC metabolite testing

    Marker Therapeutics

    Obesity &Amp;Amp;Amp; Overweight

    other active

    1 trial
  25. Vitamin D3

    Hospital Authority, Hong Kong

    Overweight and Obesity

    other completed

    1 trial
  26. Whole peanuts without skins, Peanut butter, or no peanuts (control)

    United Therapeutics Europe Ltd

    Type 2 Diabetes Mellitus

    other completed

    1 trial
  27. Xuebi formula

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diabetic Peripheral Neuropathy

    small molecule active

    1 trial
  28. bitter melon peptides

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diabetes

    other active

    1 trial
  29. human cord blood-derived mononuclear cells (HCB-MNCs)

    The First People's Hospital of Lianyungang

    Refractory Diabetic Foot

    mab active

    1 trial
  30. insulin aspart

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Type 2 Diabetes Mellitus

    small molecule active

    1 trial
  31. insulin injection 15 minutes before meals

    The First People's Hospital of Lianyungang

    Diabetes

    small molecule active

    1 trial
  32. metformin, topiramate

    Hospital Authority, Hong Kong

    Obesity

    small molecule completed

    1 trial
  33. multi-factorial intervention

    United Therapeutics Europe Ltd

    Type 2 Diabetes Mellitus

    small molecule active

    1 trial
  34. omega-3 polyunsaturated fatty acids

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Type 2 Diabetes Mellitus

    other completed

    1 trial
  35. the traditional Chinese medicine prescription ' Shenzhuo Decoction '

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diabetic Kidney Disease (DKD)

    small molecule active

    1 trial

Frequently asked questions

How many metabolic & obesity pipeline programs are tracked?

755 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Data attribution: Data sources Β· All pipeline programs